John Cox

Affiliations

  • Ceo & President at Dyne Therapeutics Inc. (DYN), 2024-09-04
  • at Sigilon Therapeutics Inc. (SGTX), 2023-08-11
  • Director at Repligen Corp (RGEN), 2020-03-26
  • Chief Executive Officer at Bioverativ Inc. (BIVV), 2018-03-08
  • Evp Pharmaceutical Oper & Tech at Biogen Inc. (BIIB), 2016-04-05
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
DYN $33.09 7,200 8,000 2024-09-04 Filing
DYN $32.57 800 800 2024-09-04 Filing
DYN $33.09 7,200 8,000 2024-09-04 Filing
DYN $32.57 800 800 2024-09-04 Filing
DYN $33.09 7,200 8,000 2024-09-04 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RGEN $96.72 1,858 Director 923 2020-03-24 Filing
RGEN $97.17 1,016 Director 2,781 2020-03-18 Filing
RGEN $96.45 1,187 Director 3,797 2020-03-18 Filing
RGEN $95.13 24,533 Director 4,984 2020-03-18 Filing
RGEN $93.39 10,000 Director 2,781 2020-03-04 Filing